JPRN-jRCT2031210003进行中（未招募）未知
Drug Use Surveillance for Cabometyx Tablets Renal Cell Carcinoma
Contact for Clinical Trial Information0 个研究点目标入组 388 人开始时间: 2021年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 388
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with radically unresectable or metastatic renal cell carcinoma who do not meet the following exclusion criterion are eligible.
排除标准
- •A patient who has a history of hypersensitivity to any component of cabozantinib
研究者
相似试验
已完成
不适用
Survey of Cabozantinib Used To Treat People With Renal Cell CarcinomaRenal Cell CarcinomaNCT04804813Takeda388
未知
Unknown
Drug use surveillance of Takecab for Supplement to Helicobacter pylori eradicatioThe following diseases in patients for whom H. pylori will be eradicated with triple therapy: Gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, idiopathic thrombocytopenic purpura, stomach following endoscopic treatment of early gastric cancer, or H. pylori gastritisJPRN-jRCT1080222951TAKEDA PHARMACEUTICAL COMPANY LTD.500
尚未招募
Unknown
Prescription pattern and side effects analysis in pediatric ICCTRI/2023/12/060816Maulana azad medical college
已完成
不适用
Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular CarcinomaHepatocellular CancerNCT05100082Takeda263
进行中（未招募）
不适用
Protocol Number; CLCZ696B1401Chronic Heart FailureJPRN-jRCT2031200432Sugimoto Toshiya660